-
EP2296631
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2296631
| EP2296631 - METHOD FOR MANUFACTURING MEDICINAL COMPOUNDS CONTAINING DABIGATRAN [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 26.07.2013 Database last updated on 04.06.2024 | Most recent event Tooltip | 26.07.2013 | Application deemed to be withdrawn | published on 28.08.2013 [2013/35] | Applicant(s) | For all designated states Boehringer Ingelheim International GmbH Binger Strasse 173 55216 Ingelheim am Rhein / DE | [N/P] |
| Former [2011/12] | For all designated states Boehringer Ingelheim International GmbH Binger Straße 173 55216 Ingelheim am Rhein / DE | Inventor(s) | 01 /
RADTKE, Guido Bernhard Edmund Boehringer Ingelheim GmbH CD Patents Binger Str. 173 55216 Ingelheim am Rhein / DE | [2011/12] | Representative(s) | Simon, Elke Anna Maria, et al Boehringer Ingelheim GmbH Binger Strasse 173 55216 Ingelheim am Rhein / DE | [2012/40] |
| Former [2011/12] | Hammann, Heinz, et al Boehringer Ingelheim GmbH Corporate Patents Binger Strasse 173 55216 Ingelheim am Rhein / DE | Application number, filing date | 09797482.8 | 13.07.2009 | [2011/12] | WO2009EP58900 | Priority number, date | EP20080160335 | 14.07.2008 Original published format: EP 08160335 | [2011/12] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2010007016 | Date: | 21.01.2010 | Language: | EN | [2010/03] | Type: | A1 Application with search report | No.: | EP2296631 | Date: | 23.03.2011 | Language: | EN | The application published by WIPO in one of the EPO official languages on 21.01.2010 takes the place of the publication of the European patent application. | [2011/12] | Search report(s) | International search report - published on: | EP | 21.01.2010 | Classification | IPC: | A61K9/16, A61K47/38, A61K31/4439 | [2011/12] | CPC: |
A61K9/4816 (EP,US);
A61K9/08 (KR);
A61K9/1682 (US);
A61K31/4439 (EP,KR,US);
A61K47/38 (KR);
A61K9/16 (KR);
A61K9/485 (EP,US);
A61K9/4866 (EP,US);
A61K9/5078 (EP,US);
A61P7/02 (EP)
(-)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR [2011/12] | Title | German: | VERFAHREN ZUR HERSTELLUNG VON ARZNEIMITELZUSAMMENSETZUNGEN ENTHALTEND DABIGATRAN | [2011/12] | English: | METHOD FOR MANUFACTURING MEDICINAL COMPOUNDS CONTAINING DABIGATRAN | [2011/12] | French: | PROCÉDÉ DE FABRICATION DE COMPOSÉS MÉDICINAUX CONTENANT DU DABIGATRAN | [2011/12] | Entry into regional phase | 14.02.2011 | National basic fee paid | 14.02.2011 | Designation fee(s) paid | 14.02.2011 | Examination fee paid | Examination procedure | 14.02.2011 | Examination requested [2011/12] | 03.03.2011 | Amendment by applicant (claims and/or description) | 07.06.2011 | Despatch of a communication from the examining division (Time limit: M06) | 19.11.2011 | Reply to a communication from the examining division | 20.08.2012 | Despatch of a communication from the examining division (Time limit: M06) | 01.03.2013 | Application deemed to be withdrawn, date of legal effect [2013/35] | 09.04.2013 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2013/35] | Divisional application(s) | EP13170832.3 / EP2638897 | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 07.06.2011 | Fees paid | Renewal fee | 01.08.2011 | Renewal fee patent year 03 | 31.07.2012 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [AD]WO9837075 (BOEHRINGER INGELHEIM PHARMA [DE]) [AD] 1-15 * the whole document *; | [XD]WO03074056 (BOEHRINGER INGELHEIM PHARMA [DE], et al) [XD] 1-15 * examples 1-3 * * claims 1-15 *; | [YD]WO2005028468 (BOEHRINGER INGELHEIM INT [DE], et al) [YD] 1-15 * the whole document *; | [Y]DE102005020002 (BOEHRINGER INGELHEIM PHARMA [DE]) [Y] 1-15 * the whole document *; | [Y]DE102005025728 (BOEHRINGER INGELHEIM PHARMA [DE]) [Y] 1-15 * the whole document *; | [A] - MUNGALL D, "BIBR-1048 BOEHRINGER INGELHEIM", CURRENT OPINION IN INVESTIGATIONAL DRUGS, PHARMAPRESS, US, (20020601), vol. 3, no. 6, ISSN 1472-4472, pages 905 - 907, XP001147306 [A] 1-15 * the whole document * |